. 2016; 33(2): 135-140 | DOI: 10.4274/tjh.2014.0405 | |||
Akut Miyeloid Lösemili Hastalarda Solubl Ürokinaz Plazminojen Aktivatör Reseptörünün Prognozdaki ÖnemiNergiz Erkut1, Ahmet Menteşe3, Hasan Mücait Özbaş2, Nilay Ermantaş2, Ayşegül Sümer4, Asım Örem4, Mehmet Sönmez21Kanuni Training and Research Hospital, Clinic of Hematology, Trabzon, Turkey2Karadeniz Technical University Faculty of Medicine, Department of Hematology, Trabzon, Turkey 3Karadeniz Technical University, Vocational School of Health Sciences, Program of Medical Laboratory Techniques, Trabzon, Turkey 4Karadeniz Technical University Faculty of Medicine, Department of Medical Biochemistry, Trabzon, Turkey GİRİŞ ve AMAÇ: Solubl ürokinaz plazminojen aktivatör reseptörü (süPAR) çeşitli immün sistem ve kanser hücrelerinde eksprese edilen ürokinaz plazminojen aktivatör reseptörün çözünür formudur. Çeşitli kanserlerde süPAR düzeyinin prognoz ile ilişkili olduğu gösterilmiştir. Bu çalışmada akut miyeloid lösemili (AML) hastalarda süPAR düzeyi ve prognoz üzerine olan etkisinin araştırılması planlandı. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid LeukemiaNergiz Erkut1, Ahmet Menteşe3, Hasan Mücait Özbaş2, Nilay Ermantaş2, Ayşegül Sümer4, Asım Örem4, Mehmet Sönmez21Kanuni Training and Research Hospital, Clinic of Hematology, Trabzon, Turkey2Karadeniz Technical University Faculty of Medicine, Department of Hematology, Trabzon, Turkey 3Karadeniz Technical University, Vocational School of Health Sciences, Program of Medical Laboratory Techniques, Trabzon, Turkey 4Karadeniz Technical University Faculty of Medicine, Department of Medical Biochemistry, Trabzon, Turkey INTRODUCTION: The soluble urokinase plasminogen activator receptor (suPAR) is a soluble form of the urokinase plasminogen activator receptor expressed in various immune and cancer cells. The levels of suPAR have been demonstrated to correlate with prognosis in various cancers. This study was intended to investigate serum suPAR levels and their effect on prognosis in patients with acute myeloid leukemia (AML). Nergiz Erkut, Ahmet Menteşe, Hasan Mücait Özbaş, Nilay Ermantaş, Ayşegül Sümer, Asım Örem, Mehmet Sönmez. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia. . 2016; 33(2): 135-140 Sorumlu Yazar: Nergiz Erkut, Türkiye |
|